Consolidating the Digital Slide: How Agilent's $270M Proscia Acquisition Signals the End of Standalone Pathology AI
Dr. Dereck Mush, MD, MBA
Mika Health
Offers a digital therapeutic application designed to support cancer patients during therapy.
What they do
Mika Health develops a digital oncology companion application that provides personalized therapy support to cancer patients. The software delivers cognitive behavioral therapy techniques, symptom tracking, and educational content, helping patients manage psychological distress and physical side effects of cancer treatment.
The record
- Vertical
- Oncology
- Sub-segment
- Patient companion software
- Product type
- Software as a medical device
- Stage
- Series B
- Headquarters
- Berlin, Germany
- Region
- Europe
- Founded
- 2017
- Total funding
- $15M raised
Notable investors: Debiopharm Innovation Fund, Kopp Venture Capital, Ananda Impact Ventures, Rheingau Founders.
Also in Oncology
Related on The Signal
Dr. Dereck Mush, MD, MBA
Mobile Clinics Lean on Scheduling Software to Reach the Patients Who Need Them Most
Dr. Dereck Mush, MD, MBA
The AI-Native Practice Playbook: Why Epsilon Health Built a Medical Group Instead of Selling Software
Dr. Dereck Mush, MD, MBA
Beyond PD-L1: How the I3LUNG Consortium Validated Multimodal AI in 2,365 Advanced Lung Cancer Patients
Dr. Dereck Mush, MD, MBA